Ashland Inc. (ASH)
| Market Cap | 2.50B -0.6% |
| Revenue (ttm) | 1.81B -7.2% |
| Net Income | -706.00M |
| EPS | -15.52 |
| Shares Out | 45.79M |
| PE Ratio | n/a |
| Forward PE | 13.77 |
| Dividend | $1.66 (3.02%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 23,918 |
| Open | 55.22 |
| Previous Close | 55.01 |
| Day's Range | 53.85 - 56.43 |
| 52-Week Range | 46.30 - 65.65 |
| Beta | 0.40 |
| Analysts | Buy |
| Price Target | 64.88 (+18.62%) |
| Earnings Date | Apr 28, 2026 |
About ASH
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemi... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for ASH stock is "Buy." The 12-month stock price target is $64.88, which is an increase of 18.62% from the latest price.
News
Ashland upgraded to Buy from Neutral at Seaport Research
Seaport Research analyst Michael Harrison upgraded Ashland (ASH) to Buy from Neutral with a $75 price target The company reported weaker than expected Q2 and reduced its fiscal 2026 guidance,…
Ashland board authorizes quarterly dividend
WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock whic...
Ashland price target lowered to $58 from $63 at Morgan Stanley
Morgan Stanley analyst Steven Haynes lowered the firm’s price target on Ashland (ASH) to $58 from $63 and keeps an Equal Weight rating on the shares.
Ashland price target lowered to $60 from $70 at Deutsche Bank
Deutsche Bank analyst David Begleiter lowered the firm’s price target on Ashland (ASH) to $60 from $70 and keeps a Buy rating on the shares.
Ashland price target lowered to $65 from $70 at JPMorgan
JPMorgan lowered the firm’s price target on Ashland (ASH) to $65 from $70 and keeps an Overweight rating on the shares.
Ashland Earnings Call Transcript: Q2 2026
Q2 results showed resilient demand and strong cash flow, but margins were pressured by operational disruptions at Calvert City and Hopewell. Updated 2026 guidance reflects stable core markets, ongoing innovation, and prudent management amid macro uncertainty.
Ashland reports Q2 adjusted EPS 91c, consensus 94c
Reports Q2 revenue $482M, consensus $485.61M. “Ashland’s (ASH) second quarter results reflect commercial execution across much of the portfolio as we navigated a challenging operating environment with...
Ashland lowers FY26 revenue view to $1.84B-$1.87B from $1.84B-$1.91B
Consensus $1.85B. Lowers FY26 adjusted EBITDA view to $385M-$400M from $400M-$420M. The company said, “Ashland (ASH) is updating its full-year fiscal 2026 sales guidance to a range of $1,835 to…
Ashland reports second quarter fiscal 2026 results and updates full-year outlook
Sales of $482 million, up one percent from the prior-year quarter Income from continuing operations of $15 million, or $0.32 per diluted share Adjusted Income from Continuing Operations Excluding Inta...
Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast
WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2026 earnings release at approximately 5 p.m.
Ashland price target lowered to $65 from $70 at Mizuho
Mizuho lowered the firm’s price target on Ashland (ASH) to $65 from $70 and keeps an Outperform rating on the shares. The firm adjusted targets in the chemicals and packaging…
Ashland price target lowered to $56 from $70 at Argus
Argus analyst Bill Selesky lowered the firm’s price target on Ashland (ASH) to $56 from $70 and keeps a Buy rating on the shares. The company’s earnings have been hurt…
Ashland to implement pricing actions across product portfolio
Ashland (ASH) is implementing pricing actions across its life sciences, intermediates, personal care and specialty additives product portfolios globally in response to continued volatility in energy m...
Ashland implementing pricing actions across product portfolio
Ashland (ASH) is implementing pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives product portfolios globally in response to continued volatility in energy m...
Ashland implements pricing actions across product portfolio in response to market volatility
Wilmington, Del., March 23, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is implementing pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives product por...
Ashland CFO to discuss current market environment at the Gabelli Funds' 17th Annual Specialty Chemicals Symposium
WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- William C.
Ashland price target raised to $62 from $53 at Evercore ISI
Evercore ISI raised the firm’s price target on Ashland (ASH) to $62 from $53 and keeps an In Line rating on the shares.
Ashland says EPA approves petition for agrimer eco-coat polymer seed coating
Ashland (ASH) announces the United States Environmental Protection Agency has officially posted and approved its petition under the Federal Insecticide, Fungicide, and Rodenticide Act for agrimer eco-...
Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the U.S.
Ashland polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations
Ashland price target raised to $63 from $60 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Ashland (ASH) to $63 from $60 and keeps an Equal Weight rating on the shares. Following fiscal Q1 reporting, the firm says…
Ashland price target raised to $73 from $70 at UBS
UBS raised the firm’s price target on Ashland (ASH) to $73 from $70 and keeps a Buy rating on the shares.
Ashland price target lowered to $70 from $77 at JPMorgan
JPMorgan analyst Jeffrey Zekauskas lowered the firm’s price target on Ashland (ASH) to $70 from $77 and keeps an Overweight rating on the shares.
Ashland price target raised to $70 from $58 at Deutsche Bank
Deutsche Bank analyst David Begleiter raised the firm’s price target on Ashland (ASH) to $70 from $58 and keeps a Buy rating on the shares.
Ashland Earnings Call Transcript: Q1 2026
Q1 results showed resilience amid demand softness, with Life Sciences and Personal Care delivering growth and margin expansion, while Specialty Additives managed cost-driven margin gains despite lower sales. Guidance for fiscal 2026 was narrowed, with temporary operational impacts expected to be recovered later in the year.
Ashland affirms FY6 revenue view of $1.835B-$1.905B
Consensus $1.86B. Narrows FY26 adjusted EBITDA view to $400M-$420M from $400M-$430M. The updated outlook “reflects approximately $11 million of temporary impacts from the Calvert City startup delay an...